HLPR:CA:TSX-Mainstreet Health Investments Inc Subscription Rcpt (CAD)

EQUITY | Preferred Share Fixed Income | Toronto Stock Exchange

Last Closing

CAD 26.36

Change

0.00 (0.00)%

Market Cap

N/A

Volume

7.60K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-03 )

ETFs Containing HLPR:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Preferred Share Fixed Income) Market Performance vs. Exchange (Toronto Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.52% 100% F 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.52% 75% C 79% B-
Trailing 12 Months  
Capital Gain 21.70% 100% F 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.70% 75% C 78% C+
Trailing 5 Years  
Capital Gain 33.88% 100% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.88% 92% A 56% F
Average Annual (5 Year Horizon)  
Capital Gain 7.86% 100% F 66% D+
Dividend Return 7.86% 92% A 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.07% 42% F 44% F
Risk Adjusted Return 39.19% 92% A 59% D-
Market Capitalization N/A N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Preferred Share Fixed Income) Ratio vs. Market (Toronto Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.